Think about all of the time, money, and care you invest in your pharmaceutical products throughout the R&D process. How terribly unfortunate it would be if damage from sub-optimal storage conditions kept them out of the market.
Alas, regulations for such important concerns as hygiene, pharmaceutical asset monitoring, labelling, quarantine, and documentation are too frequently ambiguous, unenforced, or worst of all, simply ignored.
In search of smart standards and guidelines for drug storage conditions, we consulted the Federal Drug Administration (FDA) and World Health Organization (WHO) for their recommendations. We’re hitting the highlights here, so be sure to visit their websites for more details.
HYGIENE OF PHARMACY EQUIPMENT & ASSETS
At the very least, storage areas for pharmaceutical products must be clean, dry, and orderly. More specifically:
PHARMACY REFRIGERATION TEMPERATURES
Appropriate manual or automatic temperature recording devices are your best bet for keeping your pharmaceutical products within acceptable pharma temperature limits.
PHARMACY PRODUCT LABELLING
Storage containers should be clearly labelled with all relevant information, including but not limited to:
DO NOT use unauthorized abbreviations, names or codes.
QUARANTINE
Storage areas must have physically separate spaces reserved and clearly marked for products that are:
Products so identified should be quarantined away from other pharmaceuticals until they are destroyed or returned to their supplier. Access to quarantine areas must be restricted to authorized personnel.
PHARMACY OPERATIONS DOCUMENTATION
Documenting all activities in your storage areas is time worth investing and can be easily done with pharmacy operations digital checklists and fridge temperature monitoring. Maintain inventories and records for:
Read our White Paper.
You can learn more about the importance of monitoring storage conditions by consulting our White Paper, The Importance of Temperature Monitoring for Medication Safety & Efficacy. Please download it here.